Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)
Status:
Recruiting
Trial end date:
2028-12-30
Target enrollment:
Participant gender:
Summary
This study is a prospective cohort clinical trial that aims to investigate the safety and
efficacy of a combined chemoradiotherapy and immunotherapy treatment for early postoperative
cervical cancer. Specifically, this study seeks to evaluate the ability of MRD-based
screening to detect and monitor changes in MRD status at different stages of treatment, its
potential for use in monitoring patient recurrence rates and in prognosis evaluation. In
addition, this study will investigate the safety and effectiveness of chemoradiotherapy
combined with immunotherapy as a postoperative adjuvant therapy for patients identified to be
at risk of early cervical cancer based on MRD screening.